Bavencio

Active substance

avelumab

Holder

Merck nv/sa

Status

Closed

Indication

first-line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC) without disease progression following first-line platinum-based induction chemotherapy

Public documents 

Approbation

Information for the patient

Informed consent

Last update

11/08/2022